title: HIV: prevention of mother-to-child transmission.
abstract: BACKGROUND
  Over 2 million children are thought to be living with HIV/AIDS worldwide, of whom over 80% live in sub-Saharan Africa. Without antiretroviral treatment, the risk of HIV transmission from infected mothers to their children is 15% to 30% during gestation or labour, with an additional transmission risk of 10% to 20% associated with prolonged breastfeeding. HIV-1 infection accounts for most infections; HIV-2 is rarely transmitted from mother to child. Transmission is more likely in mothers with high viral loads, advanced disease, or both, in the presence of other sexually transmitted diseases, and with increased exposure to maternal blood. Mixed feeding practices (breast milk plus other liquids or solids) and prolonged breastfeeding are also associated with increased risk of mother-to-child transmission of HIV.
  
  
  METHODS
  We conducted a systematic review and aimed to answer the following clinical question: What are the effects of measures to reduce mother-to-child transmission of HIV? We searched: Medline, Embase, The Cochrane Library, and other important databases up to October 2009 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA). We performed a GRADE evaluation of the quality of evidence for interventions.
  
  
  RESULTS
  We found 53 systematic reviews, RCTs, or observational studies that met our inclusion criteria.
  
  
  CONCLUSIONS
  In this systematic review we present information relating to the effectiveness and safety of the following interventions: antiretroviral drugs, different methods of infant feeding, elective caesarean section, immunotherapy, micronutrient supplements, vaginal microbicides, and vitamin supplements.
authors.affiliation: International Center for AIDs Care & Treatment Programs, Columbia University, New York, USA.
authors.forename: Chloe A
authors.initials: CA
authors.lastname: Teasdale
authors.forename: Ben J
authors.initials: BJ
authors.lastname: Marais
authors.forename: Elaine J
authors.initials: EJ
authors.lastname: Abrams
mesh_terms: D002648:Child; D015658:HIV Infections / Q000188:drug therapy; D015497:HIV-1; D015498:HIV-2; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D009035:Mothers